CARA Insider Trading

Insider Ownership Percentage: 4.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $226,869.62

Cara Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cara Therapeutics Share Price & Price History

Current Price: $1.06
Price Change: Price Increase of +0.09 (9.28%)
As of 12/1/2023 01:00 AM ET

This chart shows the closing price history over time for CARA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

Cara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/2/2023Christopher PosnerCEOSell3,796$1.22$4,631.12164,411View SEC Filing Icon  
8/3/2023Christopher PosnerCEOSell4,307$3.07$13,222.49168,207View SEC Filing Icon  
6/23/2023Frederique Ph.D. MenzaghiSVPSell2,993$3.51$10,505.43153,747View SEC Filing Icon  
6/23/2023Scott TerrillionInsiderSell2,483$3.51$8,715.3388,563View SEC Filing Icon  
5/5/2023Christopher PosnerCEOSell3,869$4.40$17,023.60172,514View SEC Filing Icon  
4/4/2023Frederique Ph.D. MenzaghiSVPSell2,733$4.91$13,419.03156,740View SEC Filing Icon  
4/4/2023Scott TerrillionInsiderSell2,481$4.91$12,181.7191,046View SEC Filing Icon  
2/2/2023Christopher PosnerCEOSell4,191$11.80$49,453.80182,370View SEC Filing Icon  
1/17/2023Joana GoncalvesInsiderSell2,265$10.81$24,484.6567,371View SEC Filing Icon  
12/21/2022Frederique Ph.D. MenzaghiSVPSell3,506$11.27$39,512.62166,275View SEC Filing Icon  
12/21/2022Joana GoncalvesInsiderSell2,992$11.27$33,719.8471,901View SEC Filing Icon  
11/16/2022Christopher PosnerCEOSell14,470$11.13$161,051.10186,561View SEC Filing Icon  
9/14/2022Martin VogelbaumDirectorSell10,800$10.28$111,024.0044,988View SEC Filing Icon  
7/15/2022Jeffrey L. IvesDirectorSell3,600$9.05$32,580.0015,476View SEC Filing Icon  
4/4/2022Christopher PosnerCEOSell2,006$12.67$25,416.02201,031View SEC Filing Icon  
4/1/2022Frederique Ph.D. MenzaghiSVPSell1,784$11.91$21,247.44169,781View SEC Filing Icon  
4/1/2022Scott TerrillionInsiderSell1,642$11.91$19,556.2274,893View SEC Filing Icon  
3/3/2022Scott TerrillionInsiderSell1,787$11.38$20,336.06View SEC Filing Icon  
3/3/2022Thomas Charles ReillyCFOSell2,044$11.38$23,260.72View SEC Filing Icon  
2/25/2022Scott TerrillionInsiderSell1,972$10.29$20,291.88View SEC Filing Icon  
11/12/2021Jeffrey L. IvesDirectorSell8,180$16.04$131,207.20View SEC Filing Icon  
11/1/2021Joana GoncalvesInsiderSell1,000$17.15$17,150.00View SEC Filing Icon  
10/27/2021Joana GoncalvesInsiderSell1,000$15.00$15,000.00View SEC Filing Icon  
9/7/2021Derek T. ChalmersCEOSell20,000$15.47$309,400.00991,405View SEC Filing Icon  
8/30/2021Derek T ChalmersCEOSell8,440$14.20$119,848.001,011,405View SEC Filing Icon  
8/30/2021Frederique Ph.D. MenzaghiSVPSell3,847$14.20$54,627.40141,072View SEC Filing Icon  
8/30/2021Scott TerrillionInsiderSell1,759$14.20$24,977.8047,900View SEC Filing Icon  
8/30/2021Thomas Charles ReillyCFOSell1,982$14.20$28,144.40View SEC Filing Icon  
6/7/2021Martin VogelbaumDirectorSell8,640$13.05$112,752.0028,800View SEC Filing Icon  
4/21/2021Joana GoncalvesInsiderSell3,000$27.63$82,890.0043,610View SEC Filing Icon  
3/22/2021Joana GoncalvesInsiderSell3,000$19.65$58,950.0030,610View SEC Filing Icon  
3/5/2021Derek T ChalmersCEOSell3,103$17.98$55,791.94953,614View SEC Filing Icon  
3/5/2021Frederique Ph.D. MenzaghiSVPSell3,358$17.98$60,376.84122,677View SEC Filing Icon  
3/5/2021Scott TerrillionInsiderSell3,090$17.98$55,558.2054,432View SEC Filing Icon  
2/25/2021Derek T ChalmersCEOSell11,729$19.33$226,721.57955,343View SEC Filing Icon  
2/25/2021Frederique Ph.D. MenzaghiSVPSell5,003$19.33$96,707.99117,680View SEC Filing Icon  
2/25/2021Scott TerrillionInsiderSell4,004$19.33$77,397.3248,436View SEC Filing Icon  
1/21/2021Joana GoncalvesInsiderSell2,000$20.12$40,240.0028,075View SEC Filing Icon  
12/30/2020Derek T ChalmersCEOSell6,078$15.30$92,993.40936,593View SEC Filing Icon  
12/30/2020Frederique Ph.D. MenzaghiSVPSell2,812$15.30$43,023.60109,680View SEC Filing Icon  
12/30/2020Scott TerrillionInsiderSell1,946$15.30$29,773.8042,436View SEC Filing Icon  
12/28/2020Derek T ChalmersCEOSell5,000$16.00$80,000.00947,671View SEC Filing Icon  
12/21/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0027,373View SEC Filing Icon  
12/16/2020Derek T ChalmersCEOSell5,000$14.95$74,750.00928,921View SEC Filing Icon  
12/10/2020Derek T ChalmersCEOSell7,500$15.29$114,675.00933,921View SEC Filing Icon  
See Full Table
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

68.04% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CARA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/1/2023B. Riley Wealth Advisors Inc.55,648$93K0.0%-64.1%0.102%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.1,444,088$2.43M0.0%+41.2%2.670%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al93,116$0.16M0.0%-51.2%0.172%Search for SEC Filing on Google Icon
11/16/2023Penserra Capital Management LLC81,542$0.14M0.0%-49.5%0.151%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC646,888$1.09M0.0%N/A1.196%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC58,750$99K0.0%N/A0.109%Search for SEC Filing on Google Icon
11/13/2023Stifel Financial Corp196,420$0.33M0.0%+9.6%0.363%Search for SEC Filing on Google Icon
11/13/2023Clearbridge Investments LLC971,610$1.63M0.0%-2.7%1.797%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC228,675$0.38M0.0%N/A0.423%Search for SEC Filing on Google Icon
11/13/2023FMR LLC163,169$0.27M0.0%+7.1%0.302%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.44,821$75K0.0%-24.0%0.083%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG24,983$42K0.0%-30.9%0.046%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.578,808$0.97M0.0%+76.8%1.070%Search for SEC Filing on Google Icon
11/6/2023Assenagon Asset Management S.A.65,608$0.11M0.0%N/A0.121%Search for SEC Filing on Google Icon
10/25/2023Mackenzie Financial Corp31,349$51K0.0%N/A0.058%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp165,252$0.28M0.0%-12.6%0.306%Search for SEC Filing on Google Icon
10/24/2023Pinnacle Associates Ltd.649,253$1.09M0.0%-3.4%1.201%Search for SEC Filing on Google Icon
10/18/2023IQ EQ FUND MANAGEMENT IRELAND Ltd848,845$1.43M0.3%+904.2%1.570%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC67,954$0.11M0.0%+36.1%0.126%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC9,346$26K0.0%-67.1%0.017%Search for SEC Filing on Google Icon
9/7/2023Jag Capital Management LLC11,235$32K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/21/2023California State Teachers Retirement System15,558$44K0.0%-72.6%0.029%Search for SEC Filing on Google Icon
8/15/2023Alliancebernstein L.P.93,220$0.26M0.0%+96.7%0.172%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN44,717$0.13M0.0%+12.1%0.083%Search for SEC Filing on Google Icon
8/15/2023Public Employees Retirement System of Ohio87,603$0.25M0.0%N/A0.162%Search for SEC Filing on Google Icon
8/15/2023Walleye Capital LLC140,392$0.40M0.0%N/A0.260%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP631,351$1.79M0.0%+1,385.2%1.167%Search for SEC Filing on Google Icon
8/15/2023XTX Topco Ltd52,025$0.15M0.0%-51.7%0.096%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.285,851$0.81M0.0%-5.9%0.529%Search for SEC Filing on Google Icon
8/15/2023Point72 Middle East FZE55,798$0.16M0.0%+342.2%0.103%Search for SEC Filing on Google Icon
8/15/2023Stifel Financial Corp179,241$0.51M0.0%+43.3%0.331%Search for SEC Filing on Google Icon
8/15/2023Bain Capital Life Sciences Investors LLC934,898$2.65M0.3%-57.6%1.729%Search for SEC Filing on Google Icon
8/14/2023PDT Partners LLC85,088$0.24M0.0%-16.6%0.157%Search for SEC Filing on Google Icon
8/14/2023Ergoteles LLC358,275$1.01M0.0%N/A0.662%Search for SEC Filing on Google Icon
8/14/2023Tudor Investment Corp Et Al190,989$0.54M0.0%+43.1%0.353%Search for SEC Filing on Google Icon
8/14/2023Tower Research Capital LLC TRC 9,070$26K0.0%+117.3%0.017%Search for SEC Filing on Google Icon
8/14/2023Two Sigma Securities LLC24,086$68K0.0%+103.3%0.045%Search for SEC Filing on Google Icon
8/14/2023Marshall Wace LLP133,134$0.38M0.0%N/A0.246%Search for SEC Filing on Google Icon
8/14/2023Shay Capital LLC12,500$35K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/14/2023State Street Corp919,458$2.60M0.0%-51.7%1.700%Search for SEC Filing on Google Icon
8/14/2023MML Investors Services LLC57,866$0.16M0.0%+33.6%0.107%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.19,168$54K0.0%N/A0.035%Search for SEC Filing on Google Icon
8/11/2023Jag Capital Management LLC11,235$32K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC434,050$1.23M0.0%+1,120.3%0.803%Search for SEC Filing on Google Icon
8/11/2023Baird Financial Group Inc.33,042$94K0.0%N/A0.061%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.3,701,968$10.48M0.0%-51.3%6.845%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 22,104$63K0.0%+24.4%0.041%Search for SEC Filing on Google Icon
8/11/2023Clearbridge Investments LLC998,074$2.83M0.0%+105.6%1.846%Search for SEC Filing on Google Icon
8/11/2023Franklin Resources Inc.26,301$74K0.0%+75.6%0.049%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC934,302$2.64M0.0%+4.7%1.728%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.41,087$0.12M0.0%-46.1%0.076%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp409,529$1.16M0.0%-42.2%0.757%Search for SEC Filing on Google Icon
8/10/2023Russell Investments Group Ltd.34,039$96K0.0%+2,524.4%0.063%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.327,420$0.93M0.0%-2.5%0.607%Search for SEC Filing on Google Icon
8/10/2023Citigroup Inc.58,942$0.17M0.0%-16.4%0.109%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP403,040$1.14M0.0%-57.4%0.747%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC77,618$0.22M0.0%+24.1%0.144%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.17,900$51K0.0%-93.6%0.033%Search for SEC Filing on Google Icon
8/7/2023Mirabella Financial Services LLP14,257$40K0.0%N/A0.026%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC9,346$26K0.0%-67.1%0.017%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp189,175$0.54M0.0%-53.3%0.351%Search for SEC Filing on Google Icon
7/27/2023B. Riley Wealth Advisors Inc.154,990$0.44M0.0%+218.6%0.287%Search for SEC Filing on Google Icon
7/27/2023Pinnacle Associates Ltd.672,440$1.90M0.0%-1.0%1.246%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC22,158$63K0.0%+2,846.5%0.041%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC22,158$63K0.0%+2,846.5%0.041%Search for SEC Filing on Google Icon
7/18/2023Rothschild Investment Corp IL15,100$43K0.0%-46.8%0.028%Search for SEC Filing on Google Icon
7/10/2023SG Americas Securities LLC49,932$0.14M0.0%-33.5%0.093%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.244,181$1.20M0.0%-3.4%0.452%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.76,193$0.38M0.0%+10.6%0.141%Search for SEC Filing on Google Icon
5/18/2023New York State Common Retirement Fund15,979$78K0.0%-48.4%0.030%Search for SEC Filing on Google Icon
5/17/2023B. Riley Wealth Advisors Inc.48,648$0.24M0.0%+5.4%0.090%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC13,628$67K0.0%-77.2%0.025%Search for SEC Filing on Google Icon
5/16/2023State Street Corp1,902,942$9.34M0.0%+7.1%3.526%Search for SEC Filing on Google Icon
5/16/2023Squarepoint Ops LLC195,818$0.96M0.0%N/A0.363%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC892,319$4.38M0.0%+4.1%1.653%Search for SEC Filing on Google Icon
5/16/2023Bain Capital Life Sciences Investors LLC2,204,449$10.82M1.4%-18.2%4.084%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Securities LLC11,846$58K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP25,900$0.13M0.0%N/A0.048%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP163,736$0.80M0.0%N/A0.303%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG32,920$0.16M0.0%+37.1%0.061%Search for SEC Filing on Google Icon
5/15/2023Ensign Peak Advisors Inc47,620$0.23M0.0%+13.3%0.088%Search for SEC Filing on Google Icon
5/15/2023Kingdon Capital Management L.L.C.1,233,000$6.05M1.1%-7.5%2.284%Search for SEC Filing on Google Icon
5/15/2023Farallon Capital Management LLC1,995,370$9.80M0.1%-3.8%3.697%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd107,610$0.53M0.1%+669.4%0.199%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC35,568$0.18M0.0%N/A0.066%Search for SEC Filing on Google Icon
5/12/2023Stifel Financial Corp125,099$0.61M0.0%+50.8%0.232%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.7,602,683$37.33M0.0%-1.7%14.086%Search for SEC Filing on Google Icon
5/12/2023BNP Paribas Arbitrage SNC62,538$0.31M0.0%+377.1%0.116%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE760,850$3.74M0.0%+13.4%1.410%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP65,096$0.32M0.0%N/A0.121%Search for SEC Filing on Google Icon
5/12/2023Clearbridge Investments LLC485,535$2.38M0.0%+18.8%0.900%Search for SEC Filing on Google Icon
5/12/2023UBS Group AG38,801$0.19M0.0%-35.8%0.072%Search for SEC Filing on Google Icon
5/12/2023Public Sector Pension Investment Board79,385$0.39M0.0%-4.0%0.147%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP945,882$4.64M0.0%-7.0%1.752%Search for SEC Filing on Google Icon
5/12/2023Profund Advisors LLC12,079$59K0.0%N/A0.022%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP213,644$1.05M0.0%-42.5%0.396%Search for SEC Filing on Google Icon
5/11/2023Rhumbline Advisers154,817$0.76M0.0%+5.8%0.287%Search for SEC Filing on Google Icon
5/11/2023Citigroup Inc.70,535$0.35M0.0%-4.8%0.131%Search for SEC Filing on Google Icon
5/10/2023Credit Suisse AG89,605$0.44M0.0%+3.0%0.166%Search for SEC Filing on Google Icon
5/10/2023Swiss National Bank98,600$0.48M0.0%-10.5%0.183%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cara Therapeutics logo
Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate, including Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. Cara Therapeutics, Inc. has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Pharma for the co-development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. The company was incorporated in 2004 and is based in Stamford, Connecticut.
Read More on Cara Therapeutics

Today's Range

Now: $1.06
Low: $0.93
High: $1.10

50 Day Range

MA: $1.29
Low: $0.93
High: $1.79

52 Week Range

Now: $1.06
Low: $0.90
High: $12.81

Volume

589,721 shs

Average Volume

816,071 shs

Market Capitalization

$57.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Cara Therapeutics?

Cara Therapeutics' top insider investors include:
  1. Christopher Posner (CEO)
  2. Frederique PhD Menzaghi (SVP)
  3. Scott Terrillion (Insider)
  4. Joana Goncalves (Insider)
  5. Martin Vogelbaum (Director)
  6. Jeffrey L Ives (Director)
  7. Thomas Charles Reilly (CFO)
Learn More about top insider investors at Cara Therapeutics.

Who are the major institutional investors of Cara Therapeutics?

Cara Therapeutics' top institutional investors include:
  1. Jacobs Levy Equity Management Inc. — 2.67%
  2. Clearbridge Investments LLC — 1.80%
  3. IQ EQ FUND MANAGEMENT IRELAND Ltd — 1.57%
  4. Pinnacle Associates Ltd. — 1.20%
  5. AQR Capital Management LLC — 1.20%
  6. Charles Schwab Investment Management Inc. — 1.07%
Learn More about top institutional investors of Cara Therapeutics stock.

Which institutional investors are selling Cara Therapeutics stock?

During the last quarter, CARA stock was sold by these institutional investors:
  1. B. Riley Wealth Advisors Inc.
  2. Tudor Investment Corp Et Al
  3. Penserra Capital Management LLC
  4. Clearbridge Investments LLC
  5. Bank of New York Mellon Corp
  6. Pinnacle Associates Ltd.
  7. Citigroup Inc.
  8. UBS Group AG
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
  1. Christopher Posner (CEO)
  2. Frederique PhD Menzaghi (SVP)
  3. Scott Terrillion (Insider)
  4. Joana Goncalves (Insider)
Learn More investors selling Cara Therapeutics stock.

Which institutional investors are buying Cara Therapeutics stock?

During the previous quarter, CARA stock was purchased by institutional investors including:
  1. IQ EQ FUND MANAGEMENT IRELAND Ltd
  2. AQR Capital Management LLC
  3. Jacobs Levy Equity Management Inc.
  4. Charles Schwab Investment Management Inc.
  5. Acadian Asset Management LLC
  6. Assenagon Asset Management S.A.
  7. Algert Global LLC
  8. Mackenzie Financial Corp